Send to

Choose Destination
Perspect Clin Res. 2019 Jan-Mar;10(1):1-3. doi: 10.4103/picr.PICR_196_18.

Subject expert committees: Past, present, and future.

Author information

Head Regulatory Affairs, Global Drug Development India, Novartis Healthcare Private Ltd., Mumbai, Maharashtra, India.
Chief Scientific Officer, Novartis India Limited, Mumbai, Maharashtra, India.

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center